Cizumab is the first Bevacizumab biosimilar in Indian market launched by Hetero. Cizumab Medicine used in the treatment of Colorectal Cancer, Non-Small Cell Lung Cancer, Glioblastoma Multiforme, Renal Cell Carcinoma, Cervical, Ovarian and Fallopian Tube Cancer.